Received Oct 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 5 | 4L454 | IM / LL |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 2 | Z007578 | SC / RL |
5CM X 4.5 CM AREA OF MILD ERYTHEMA NOTED TO LEFT LATERAL ANTERIOR THIGH. 2CM AREA OF FIRM INDURATION NOTED DIRECTLY UNDER INJECTION SITE. OVERLYING SKIN IS NOT WARM TO PALPITATION. PATIENT REMAINS FULL RANGE OF MOTION OF LEG, NO REPRODUCIBLE PAIN WITH PALPATION. AREA OF REDNESS LIKELY INDICATES MONITORING OVER THE NEXT 24 HRS. SHOULD REDNESS CONTINUE TO SPREAD START ORAL ANTIBIOTICS AS PRESCRIBED. OTHERWISECONTINUE MONITORING AND UTILIZE TYLENOL OR IBUPROFEN, WARM/COOL COMPRESS AND ENCOURAGE LOWER PHYSICAL ACTIVITY. MOTHER WAS ENCOURAGED TO SEEK MEDICAL ATTENTION SOONER IF NEEDED FOR WORSENING SIGNS OR SYMPTOMS. SHE STATED UNDERSTANDING AND HAS NO OTHER CONCERNS. ORDERED ON 10/06/2025 KEFLEX 125MG/5 ML SUSPENSION; TAKE 6.4MLS BY MOUTH 3X DAILY FOR 7 DAYS
NONE
NONE
NONE
NKDA
NONE